Pawsey Supercomputing Centre
Mark Stickells, executive director at Pawsey Supercomputing Centre, highlights the work done in Australia to deliver supercomputing facilities and the resources needed
The Pawsey Supercomputing Centre has announced the Pawsey Supercomputing Centre for Extreme scale Readiness (PACER) programme to help computational researchers and prepare them for the next era of supercomputing
Pawsey Supercomputing Centre announces the appointment of WA based Mr Mark Stickells, as the new Director of the Centre effective 16 July 2018.
Making the announcement Mr John Langoulant, hair of the Pawsey Supercomputing Centre, said: ‘after undertaking a rigorous selection process, we welcome Mark to this crucial position.’
A new GPU Hackathon event is taking place this week in Perth Australia to highlight the importance of developing GPU technology and expertise
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
